- Home
- NRXP vs WIMI Comparison
NRXP vs WIMI Comparison
Compare NRXP & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- WIMI
- Stock Information
- Founded
- NRXP 2015
- WIMI 2015
- Country
- NRXP United States
- WIMI China
- Employees
- NRXP N/A
- WIMI N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- WIMI Computer Software: Prepackaged Software
- Sector
- NRXP Health Care
- WIMI Technology
- Exchange
- NRXP Nasdaq
- WIMI Nasdaq
- Market Cap
- NRXP 58.5M
- WIMI 51.6M
- IPO Year
- NRXP N/A
- WIMI 2020
- Fundamental
- Price
- NRXP $2.92
- WIMI $3.94
- Analyst Decision
- NRXP Strong Buy
- WIMI
- Analyst Count
- NRXP 5
- WIMI 0
- Target Price
- NRXP $31.40
- WIMI N/A
- AVG Volume (30 Days)
- NRXP 435.6K
- WIMI 242.2K
- Earning Date
- NRXP 11-13-2025
- WIMI 01-01-0001
- Dividend Yield
- NRXP N/A
- WIMI N/A
- EPS Growth
- NRXP N/A
- WIMI N/A
- EPS
- NRXP N/A
- WIMI 1.43
- Revenue
- NRXP N/A
- WIMI $61,329,146.00
- Revenue This Year
- NRXP N/A
- WIMI N/A
- Revenue Next Year
- NRXP $395.09
- WIMI N/A
- P/E Ratio
- NRXP N/A
- WIMI $2.78
- Revenue Growth
- NRXP N/A
- WIMI N/A
- 52 Week Low
- NRXP $1.12
- WIMI $2.24
- 52 Week High
- NRXP $6.01
- WIMI $29.20
- Technical
- Relative Strength Index (RSI)
- NRXP 41.65
- WIMI 43.34
- Support Level
- NRXP $3.05
- WIMI $3.80
- Resistance Level
- NRXP $3.32
- WIMI $4.16
- Average True Range (ATR)
- NRXP 0.22
- WIMI 0.26
- MACD
- NRXP -0.05
- WIMI -0.03
- Stochastic Oscillator
- NRXP 0.74
- WIMI 34.02
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.